AHA/CHF Congenital Heart Defect Research Awards
The AHA/CHF Congenital Heart Defect Research Awards fund innovative research on the prevention, diagnosis, and treatment of congenital heart defects, supported by The Children's Heart Foundation.
Funder: The Children's Heart Foundation
Due Dates (Anticipated): February 2027 (annual application deadline, projected)
Funding Amounts: Recent cycles have awarded $625,000–$1.3M total per year; typical individual project awards range from $100,000–$200,000 over 2 years.
Summary: Supports innovative research advancing the prevention, diagnosis, and treatment of congenital heart defects through a partnership between The Children's Heart Foundation and the American Heart Association.
Description
This program is a collaborative initiative between The Children's Heart Foundation and the American Heart Association, designed to support high-impact research on congenital heart defects (CHDs). The awards specifically fund investigators focused on advancing the prevention, diagnosis, and treatment of CHDs. The partnership aims to drive scientific discovery and innovation to improve outcomes and quality of life for individuals—especially children—affected by congenital heart conditions. Funding is typically directed toward basic, clinical, population, or translational research, and both predoctoral and postdoctoral investigators are eligible.
